Skip to main content
Premium Trial:

Request an Annual Quote

French Commission of Atomic Energy, Sir Mortimer B. Davis-Jewish General Hospital, Harvard University


The French Commission of Atomic Energy received US Patent No. 6,510,237, “System for determining the concentration of a substance mixed with a fluorophor, its method of implementation.” The patent covers a reader used in analysis of the Micam-brand DNA chips produced by the commission’s Laboratory of Electronics, Technology and Instrumentation (LETI). The technology determines the concentration of a substance mixed with a fluorophor and contained in an electrically addressable matrix on a reflective carrier. It comprises: a microscope to view the image of the fluorescence of one of the contacts of the matrix, illuminating with a first beam to enable image acquisition in white light, and a second beam to excite the fluorophor contained in the contact; a way to view the contact image; and means to process the image. The equipment used includes a pulsated micro laser, a cooled CCD camera, and a high-pass filter.

The Sir Mortimer B. Davis-Jewish General Hospital of Montreal received US Patent 6,511,849, “Microarrays of biological materials.” The patent covers “relatively simple and inexpensive machinery” to automate the manufacture of microarrays in a reproducible and rapid manner. The process uses ink-jet technology to deposit minute quantities of liquid on a solid substrate. The equipment can be constructed from commercially available components. Part of the technology is a system for cleaning parts of the system to avoid contamination.

Harvard University earned US Patent No. 6,511,803, “Replica amplification of nucleic acid arrays.” The patent covers a method for producing replicas of microarrays and for preserving the resolution through rounds of replication. The patent abstract says the chips can be produced for about $10 a chip and can be reused. The process is described thusly: 1) providing a pool of nucleic acid molecules, 2) plating or other transfer of the pool onto a solid support, 3) in situ amplification, 4) replica printing of the amplified nucleic acids, and 5) identification of features.


The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.